6Sultzer DL, Davis SM, Tariot PN, et al. Clinical symptom responses to atypical antipsychotic medications in Alzheimer's disease: phase Ⅰ outcomes from the CATIE-AD effectiveness trial[J]. Am J Psychiatry, 2008, 165 (7) : 844-854.
7Lee PE, Gill SS, Freedman M, et al. Atypical antipsychotic drugs in the treatment of behavioural and psychological symptoms of dementia: systematic review [J]. Br Med J, 2004, 329 (7457) : 75-78.
8Madhusoodanan S, Shah P. Management of psychosis in patients with Alzheimer's disease: focus on aripiprazole [J]. Clin Interv Aging, 2008, 3 (3) : 491-501.
9De Deyn P, Jeste DV, Swanink R, et al. Aripiprazole for the treatment of psychosis in patients with Alzheimer's disease: a randomized, placebocontrolled study [J]. J Clin Psychopharmacol, 2005, 25 (5) : 463-467.
10Streim JE, Porsteinsson AP, Breder CD, et al. randomized, double-blind, placebo-controlled study of aripiprazole for the treatment of psychosis in nursing home patients with Alzheimer disease [J]. Am J Geriatr psychiatry, 2008, 16(7) :537-550.
7Xu H, Wang H, Zhuang L, et al. Demonstration of an antioxidative stress mechanism of quetiapine: implications for the treatment of Alzheimer's disease[J].IFE1]S J, 2008, 275 (14) : 3718-3728.
8Savaskan E, Schnitzler C, Schroder C, et al. Treatment of behavioural, cognitive and circadian rest-activity cycle disturbances in hlzheimer's disease:haloperidol vs quetiapine[J].Int J Neuropsychopharmacol, 2006, 9(5):507- 516.
